Sponsors and investigators are increasingly incorporating mobile medical applications and other virtual trial technologies into their research. Join us for a discussion to better understand the regulations and how the oversight of virtual trials might differ from what they have traditionally been used to.
Join us as we explore recommended elements of a diversity action plan for research as explained in nonbinding recommendations from the Food and Drug Administration (FDA) released in April 2022. Webinar replay expires March 22, 2026.